These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8213802)

  • 1. Health care payment policies: lessons from erythropoietin.
    Abraham PA
    Am J Kidney Dis; 1993 Oct; 22(4):596-7. PubMed ID: 8213802
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant erythropoietin and Medicare payment.
    Eggers PW
    JAMA; 1991 Nov; 266(19):2705-6. PubMed ID: 1942420
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from the University Healthsystem Consortium.
    Int J Technol Assess Health Care; 1999; 15(2):437-8. PubMed ID: 10507201
    [No Abstract]   [Full Text] [Related]  

  • 4. ESA payment changes: chasing a moving target.
    Sargent JA
    Nephrol News Issues; 2008 Jan; 22(1):36-7. PubMed ID: 18271437
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients.
    Powe NR; Griffiths RI; Anderson GF; de Lissovoy G; Watson AJ; Greer JW; Herbert RJ; Whelton PK
    Am J Kidney Dis; 1993 Oct; 22(4):557-67. PubMed ID: 8213796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding a rational approach to ESA therapy--for payers and patients.
    Messana A
    Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.
    Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC
    Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients get EPO subcutaneously?
    Wish JB
    Nephrol News Issues; 2006 Aug; 20(9):12. PubMed ID: 16916054
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in Medicaid prescription drug utilization and payments, 1990-97.
    Baugh DK; Pine PL; Blackwell S
    Health Care Financ Rev; 1999; 20(3):79-105. PubMed ID: 10558022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Health Care Financing Administration data for the development of a quality improvement project on the treatment of anemia.
    Eggers PW; Greer J; Jencks S
    Am J Kidney Dis; 1994 Aug; 24(2):247-54. PubMed ID: 8048432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Medicare home health benefit implications of recent payment changes.
    Bishop CE; Kerwin J; Wallack SS
    Care Manag J; 1999; 1(3):189-96. PubMed ID: 10695176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare program; coverage of epoetin (EPO) used by competent home dialysis patients--HCFA. Final rule.
    Fed Regist; 1994 Jan; 59(6):1278-85. PubMed ID: 10133081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin claims monitoring policy: implications for clinical practice.
    Messana T
    Nephrol Nurs J; 2006; 33(2):209-13, 222; quiz 214-5. PubMed ID: 16613415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in use, cost, and outcomes of human recombinant erythropoietin, 1989-98.
    Greer JW; Milam RA; Eggers PW
    Health Care Financ Rev; 1999; 20(3):55-62. PubMed ID: 10558020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from the per-episode PPS demonstration.
    Pace KB
    Caring; 1998 Feb; 17(2):14-7. PubMed ID: 10178030
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of the change in CMS billing rules for erythropoietin on hemoglobin outcomes in dialysis patients.
    Ofsthun NJ; Lazarus JM
    Blood Purif; 2007; 25(1):31-5. PubMed ID: 17170534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician payment outlook for 2012: déjà vu.
    Manchikanti L; Singh V; Caraway DL; Benyamin RM; Falco FJ; Hirsch JA
    Pain Physician; 2012; 15(1):E27-52. PubMed ID: 22270747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2005. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Nov; 69(219):66235-915. PubMed ID: 15551493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProPAC recommends a bundled Medicare payment for post acute care.
    Natl Rep Subacute Care; 1997 Mar; 5(6):1-4. PubMed ID: 10165885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.